PRL and neoplasm: The dissection of the PGE2-prolactin paracrine signaling axis between the tumor and stroma provides mechanistic insights into the pathways targeted by COX-2 inhibition, which is the most compelling and epidemiologically validated chemoprevention strategy for human PCa (78).